Published in Mediators Inflamm on May 14, 2012
The sweet tooth of bacteria: common themes in bacterial glycoconjugates. Microbiol Mol Biol Rev (2014) 0.91
Lipopolysaccharide endotoxins. Annu Rev Biochem (2001) 18.88
The effect of infections on susceptibility to autoimmune and allergic diseases. N Engl J Med (2002) 9.26
LPS, TLR4 and infectious disease diversity. Nat Rev Microbiol (2005) 5.25
Inhibition of Toll-like receptor 4 breaks the inflammatory loop in autoimmune destructive arthritis. Arthritis Rheum (2007) 2.42
Development and characterization of synthetic glucopyranosyl lipid adjuvant system as a vaccine adjuvant. PLoS One (2011) 2.39
Toll-like receptors in inflammatory bowel diseases: a decade later. Inflamm Bowel Dis (2010) 1.79
Coordination of tolerogenic immune responses by the commensal microbiota. J Autoimmun (2009) 1.62
Lipopolysaccharide O antigen status of Yersinia enterocolitica O:8 is essential for virulence and absence of O antigen affects the expression of other Yersinia virulence factors. Mol Microbiol (2004) 1.44
Systemic Toll-like receptor stimulation suppresses experimental allergic asthma and autoimmune diabetes in NOD mice. PLoS One (2010) 1.43
A novel Toll-like receptor 4 antagonist antibody ameliorates inflammation but impairs mucosal healing in murine colitis. Am J Physiol Gastrointest Liver Physiol (2009) 1.39
Bartonella quintana lipopolysaccharide is a natural antagonist of Toll-like receptor 4. Infect Immun (2007) 1.32
Structure and biological activity of the short-chain lipopolysaccharide from Bartonella henselae ATCC 49882T. J Biol Chem (2004) 1.15
Early life activation of toll-like receptor 4 reprograms neural anti-inflammatory pathways. J Neurosci (2010) 1.03
Mechanisms of endotoxin tolerance in human intestinal microvascular endothelial cells. J Immunol (2003) 1.03
Immunomodulating effects of endotoxin in mouse models of allergic asthma. Clin Exp Allergy (2010) 1.00
Early life exposure to lipopolysaccharide suppresses experimental autoimmune encephalomyelitis by promoting tolerogenic dendritic cells and regulatory T cells. J Immunol (2009) 0.98
Bartonella quintana lipopolysaccharide effects on leukocytes, CXC chemokines and apoptosis: a study on the human whole blood and a rat model. Int Immunopharmacol (2003) 0.93
Lipopolysaccharide pretreatment protects against ischemia/reperfusion injury via increase of HSP70 and inhibition of NF-κB. Cell Stress Chaperones (2010) 0.90
In vitro Bartonella quintana infection modulates the programmed cell death and inflammatory reaction of endothelial cells. Diagn Microbiol Infect Dis (2003) 0.89
Structural analysis of lipopolysaccharides from Gram-negative bacteria. Biochemistry (Mosc) (2010) 0.88
The Janus face of Bartonella quintana recognition by Toll-like receptors (TLRs): a review. Eur Cytokine Netw (2008) 0.83
Telling apart friend from foe: discriminating between commensals and pathogens at mucosal sites. Innate Immun (2010) 0.79
[Extraction and characterization of the lipopolysaccharide of Bartonella quintana] Infez Med (1999) 0.78
Inhibition of Toll-like receptor 4 breaks the inflammatory loop in autoimmune destructive arthritis. Arthritis Rheum (2007) 2.42
Impact of interleukin-10, soluble CD25 and interferon-γ on the prognosis and early diagnosis of bacteremic systemic inflammatory response syndrome: a prospective observational study. Crit Care (2013) 1.39
Bartonella quintana lipopolysaccharide is a natural antagonist of Toll-like receptor 4. Infect Immun (2007) 1.32
Changes in the prevalence of hepatitis C virus (HCV) genotype 4 in Calabria, Southern Italy. Diagn Microbiol Infect Dis (2002) 1.12
Six cases of sepsis caused by Pantoea agglomerans in a teaching hospital. New Microbiol (2009) 1.10
Giardia lamblia infection in patients with irritable bowel syndrome and dyspepsia: a prospective study. World J Gastroenterol (2006) 0.97
Bartonella quintana lipopolysaccharide effects on leukocytes, CXC chemokines and apoptosis: a study on the human whole blood and a rat model. Int Immunopharmacol (2003) 0.93
Hepatitis C virus genotype 4d in Southern Italy: reconstruction of its origin and spread by a phylodynamic analysis. J Med Virol (2012) 0.90
Eleven-year distribution pattern of hepatitis C virus in southern Italy. J Pathog (2012) 0.90
In vitro Bartonella quintana infection modulates the programmed cell death and inflammatory reaction of endothelial cells. Diagn Microbiol Infect Dis (2003) 0.89
Update on epidemiology of HCV in Italy: focus on the Calabria Region. BMC Infect Dis (2014) 0.86
Diagnosis and follow-up of Bartonella henselae infection in the spleen of an immunocompetent patient by real-time quantitative PCR. J Med Microbiol (2013) 0.85
Receptor recognition of and immune intracellular pathways for Veillonella parvula lipopolysaccharide. Clin Vaccine Immunol (2009) 0.84
An unusual case of brain abscess by Gemella morbillorum. Jpn J Infect Dis (2006) 0.84
The Janus face of Bartonella quintana recognition by Toll-like receptors (TLRs): a review. Eur Cytokine Netw (2008) 0.83
Molecular identification of Bartonella quintana infection using species-specific real-time PCR targeting transcriptional regulatory protein (bqtR) gene. Mol Cell Probes (2011) 0.81
Procalcitonin neutralizes bacterial LPS and reduces LPS-induced cytokine release in human peripheral blood mononuclear cells. BMC Microbiol (2012) 0.81
Bartonella quintana-induced apoptosis inhibition of human endothelial cells is associated with p38 and SAPK/JNK modulation and with stimulation of mitosis. Diagn Microbiol Infect Dis (2004) 0.81
Phenotypic and genotypic evaluation of slime production by conventional and molecular microbiological techniques. Microbiol Res (2007) 0.80
Typing of Ochrobactrum anthropi clinical isolates using automated repetitive extragenic palindromic-polymerase chain reaction DNA fingerprinting and matrix-assisted laser desorption/ionization-time-of-flight mass spectrometry. BMC Microbiol (2014) 0.79
Ascaris lumbricoides-induced suppression of total and specific IgE responses in atopic subjects is interleukin 10-independent and associated with an increase of CD25(+) cells. Diagn Microbiol Infect Dis (2008) 0.79
Present, old and future strategies for anti-HCV treatment in patients infected by genotype-1: estimation of the drug costs in the Calabria Region in the era of the directly acting antivirals. BMC Infect Dis (2014) 0.79
Stenotrophomonas maltophilia lipopolysaccharide (LPS) and antibiotics: "in vitro" effects on inflammatory mediators. Infez Med (2004) 0.78
Inhibition of neutrophil apoptosis after coronary bypass operation with cardiopulmonary bypass. Ann Thorac Surg (2002) 0.78
Human papillomavirus type 16 E5 protein induces expression of beta interferon through interferon regulatory factor 1 in human keratinocytes. J Virol (2011) 0.78
Chronic neuroborreliosis by B. garinii: an unusual case presenting with epilepsy and multifocal brain MRI lesions. New Microbiol (2014) 0.77
Interleukin 27 polymorphisms in HCV RNA positive patients: is there an impact on response to interferon therapy? BMC Infect Dis (2014) 0.77
Shotgun proteomic analysis of two Bartonella quintana strains. Proteomics (2013) 0.77
Challenging clinical cases in HCV infection. BMC Infect Dis (2014) 0.75
The impact of a vaccination campaign against hepatitis B on the further decrease of hepatitis B virus infection in a southern Italian town over 14 years. Eur J Intern Med (2012) 0.75
'An atypical pattern of HCV INNO-LiPA subtype'. J Clin Virol (2002) 0.75
Multiple abscesses of the left brain hemisphere due to Listeria monocytogenes in an immunocompromised patient: a case report. Infez Med (2012) 0.75